Basser oncologist Payal Shah, MD, discusses landmark approvals of targeted therapies for the treatment of BRCA-related breast cancer, as well as ongoing cancer research. 

Basser Executive Director Susan Domchek, MD, discusses typical guidelines for follow up to BRCA-related breast cancer.

On October 3, 2018, Basser YLC co-chair Erika Stallings; Rob Sorin, father of YLC member Jenny Sorin and wife of Basser Leadership Council member Helene Sorin; and writer Taylor Harris shared their personal stories on life with a BRCA mutation.

Lawyer and Basser YLC co-chair Erika Stallings shared a personal story about her experiences with dating after learning of her own mutation.

Writer Taylor Harris shared a personal story about her family and learning of her own mutation.

The Basser Center's Executive Director, Susan Domchek, MD, discusses early screening recommendations for young women with BRCA mutations.

In this ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses recent advancements in treatment options for BRCA-related cancers, such as drugs like PARP inhibitors.

Ronny Drapkin, MD, PhD, Basser’s Director of Gynecologic Cancer Research, and Penn’s Ovarian Cancer Research Center shares the latest on early detection research for ovarian cancer.

The Basser Center and the Lawrence Family Jewish Community Center presented a dynamic conversation about the experience of living with BRCA mutations and hereditary cancers. 

The Sixth Annual Basser Center Scientific Symposium on Tuesday, May 22, and Wednesday, May 23, featured Keynote speaker and Basser Global Prize awardee Professor Ashok Venkitaraman, MBSS, PhD, from the University of Cambridge.